Media Center

Making News


  • Since 2009, funding through the CRMRP has contributed to more than 10 hand/arm transplants and 4 face transplants, significantly advancing the field of vascularized composite tissue allotransplantation.
  • AFIRM investigators have enrolled more than 260 patients to date in numerous human clinical studies for the treatment of burn injuries, scar prevention, severe facial disfigurement, upper extremity amputations, soft tissue defects, and traumatic scarring.

Promising Developments

  • Successful completion of Phase 3 trial of Sufentanil NanoTabs